This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Health Winners and Losers

Shares of Providence Service (PRSC - Get Report) rose 6% after the company priced its follow-on stock offering at $32 a share. The company, which provides home- and community-based social services, priced 1.8 million shares, up from its earlier figure of 1.5 million shares. Of the 1.8 million shares, the company offered some 1.73 million, up from the company's earlier projection of 1.43 million.

The remaining shares were sold by stockholders. Providence plans to use the proceeds to pay down debt and for general corporate purposes. Shares were up $1.85 to $34.05.

Given Imaging (GIVN) fell 2% after the company, a maker of diagnostics products for disorders of the gastrointestinal tract, cut its first-quarter sales outlook and warned that earnings would be below expectations. The company estimates sales of about $20.2 million, down from an earlier view of $21 million to $23 million. Analysts polled by Thomson First Call project sales of $22.8 million.

The company also warned that, as a result of the sales shortfall, its earnings would fall short of its previous guidance of 1 cent to 3 cents a share. Analysts project earnings of 2 cents a share. Given Imaging blamed the lower-than-expected sales on a 50% ramp-up in its U.S. sales force and by the accompanying training and adjustments necessary to integrate the increased sales force.

For the full year, Given Imaging continues to expect earnings of 35 cents to 45 cents a share and sales of $110 million to $120 million. Analysts project earnings of 34 cents a share on sales of $108.4 million. Shares were down 47 cents to $22.41.

Other health care volume movers included Pfizer (PFE), down 44 cents to $24.21; UnitedHealth Group (UNH), down $1.15 to $51.28; Boston Scientific (BSX - Get Report), down 17 cents to $21.36; Merck (MRK), down 44 cents to $33.98; Johnson & Johnson (JNJ), down 25 cents to $57.46; Novavax (NVAX), down 17 cents to $4.97; Generex Biotechnology (GNBT), down 20 cents to $2.53; Amgen (AMGN), down 68 to $70.06; Bristol-Myers Squibb (BMY), down 25 cents to $24.02; and Schering-Plough (SGP), down 30 cents to $18.40.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
GIVN $0.00 0.00%
BSX $17.98 -1.96%
PRSC $47.89 -2.96%
AAPL $132.65 1.82%
FB $81.91 0.47%

Markets

DOW 18,037.97 -42.17 -0.23%
S&P 500 2,108.92 -8.77 -0.41%
NASDAQ 5,060.2460 -31.8390 -0.63%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs